Mesa Labs reports Q4 GAAP operating loss of $110k; adjusted op income ex-unusual items up 31%

MESA LABORATORIES INC /CO/

GAAP operating loss of $110k vs income of $4.3M a year ago; net loss $1.78M (-$0.34 diluted EPS).
Non-GAAP adjusted operating income (AOI) rose 11% to $11.65M; AOI ex-unusual items up 31% to $13.57M.
Total revenues grew 55% in Q4 to $58.9M, organic +12%; FY revenues up 38% to $184.3M, organic +13%.
Clinical Genomics segment revenue $16.4M including $1.4M COVID; ex-COVID below plan, China lockdowns expected to impact Q1.
FY23 guidance cautious: lower organic growth expected due to inflation, war in Europe, and Asia pandemic resurgence.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.